Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1992 1
1993 5
1994 5
1995 4
1997 2
1998 1
1999 2
2001 3
2002 1
2003 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Tolerogenic immunosuppression for organ transplantation.
Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ. Starzl TE, et al. Lancet. 2003 May 3;361(9368):1502-10. doi: 10.1016/s0140-6736(03)13175-3. Lancet. 2003. PMID: 12737859 Free PMC article.
Systematic application of these principles should allow improvements in quality of life and long-term survival after organ transplantation....
Systematic application of these principles should allow improvements in quality of life and long-term survival after organ transplant …
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S. Li W, et al. Transplantation. 2001 Oct 27;72(8):1423-32. doi: 10.1097/00007890-200110270-00016. Transplantation. 2001. PMID: 11685115
Inhibition of acute liver allograft rejection by CTLA4Ig, linked to restoration of apoptotic activity of graft-infiltrating T cells, further suggests that deletion of these cells may be critical for promotion of long-term allograft survival....
Inhibition of acute liver allograft rejection by CTLA4Ig, linked to restoration of apoptotic activity of graft-infiltrating T cells, further …
Clinical intestinal transplantation: a decade of experience at a single center.
Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, Sindhi R, Martin D, Colangelo J, Zak M, Janson D, Ezzelarab M, Dvorchik I, Parizhskaya M, Deutsch M, Demetris A, Fung J, Starzl TE. Abu-Elmagd K, et al. Ann Surg. 2001 Sep;234(3):404-16; discussion 416-7. doi: 10.1097/00000658-200109000-00014. Ann Surg. 2001. PMID: 11524593 Free PMC article.
OBJECTIVE: To assess the long-term efficacy of intestinal transplantation under tacrolimus-based immunosuppression and the therapeutic benefit of newly developed adjunct immunosuppressants and management strategies. ...RESULTS: The actuarial survival rate for the total pop …
OBJECTIVE: To assess the long-term efficacy of intestinal transplantation under tacrolimus-based immunosuppression and the therapeuti …
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ. Jain A, et al. Transplantation. 2001 Apr 27;71(8):1102-6. doi: 10.1097/00007890-200104270-00016. Transplantation. 2001. PMID: 11374410
Although the use of other immunosuppressive agents may reduce the rate of reintroduction of steroid, long-term sustained freedom from steroid may not be possible in all patients under tacrolimus secondary to these conditions....
Although the use of other immunosuppressive agents may reduce the rate of reintroduction of steroid, long-term sustained freedom from …
Should hepatomas be treated with hepatic resection or transplantation?
Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Yamamoto J, et al. Cancer. 1999 Oct 1;86(7):1151-8. doi: 10.1002/(sici)1097-0142(19991001)86:7<1151::aid-cncr8>3.0.co;2-v. Cancer. 1999. PMID: 10506698 Free PMC article.
BACKGROUND: The aim of this collaborative study was to compare the long term results of hepatic resection (Hx) with those of orthotopic liver transplantation (OLTx) in large numbers of cirrhotic patients with hepatocellular carcinoma (HCC) and to delineate the roles of the …
BACKGROUND: The aim of this collaborative study was to compare the long term results of hepatic resection (Hx) with those of orthotop …
Dendritic cells/chimerism/alleviation of chronic allograft rejection.
Murase N, Ichikawa N, Ye Q, Chun HJ, Okuda T, Demetris AJ. Murase N, et al. J Leukoc Biol. 1999 Aug;66(2):297-300. doi: 10.1002/jlb.66.2.297. J Leukoc Biol. 1999. PMID: 10449171 Review.
Chronic rejection (CR) is the major obstacle of long-term successful organ transplantation. Using a recently developed rat model of CR, we found that heart allografts susceptible to development of CR showed an early (< 10 days) dramatic disappearance of donor MHC class …
Chronic rejection (CR) is the major obstacle of long-term successful organ transplantation. Using a recently developed rat model of C …
Liver transplantation in the treatment of hepatocellular carcinoma.
Marsh JW, Dvorchik I, Iwatsuki S. Marsh JW, et al. J Hepatobiliary Pancreat Surg. 1998;5(1):24-8. doi: 10.1007/pl00009946. J Hepatobiliary Pancreat Surg. 1998. PMID: 9683750
. , pTNM stages I + II and pTNM stages I + II + III). Suitability for transplantation was judged by long-term survival rates (i.e., 1-10 years post-transplant). By using the neural network prediction model and the subsequent subgroup case analysis, it was possible to gener …
. , pTNM stages I + II and pTNM stages I + II + III). Suitability for transplantation was judged by long-term survival rates (i.e., 1 …
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, Casavilla A, Dvorchik I, Fung JJ, Starzl TE. Pinna AD, et al. Hepatology. 1997 Oct;26(4):877-83. doi: 10.1002/hep.510260412. Hepatology. 1997. PMID: 9328308 Free PMC article.
FL-HCC is an indolently growing tumor of the liver, which usually was diagnosed in our patients at a stage too advanced for effective surgical treatment of most conventional HCC. Nevertheless, long-term survival frequently was achieved with aggressive surgical treatment. . …
FL-HCC is an indolently growing tumor of the liver, which usually was diagnosed in our patients at a stage too advanced for effective surgic …
29 results